Post-market Review of Opiate Dependence Treatment Program (ODTP) Medicines

Page last updated: 24 March 2021

The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical Benefits Scheme (PBS) Opiate Dependence Treatment Program including consideration of patient access and affordability. The Pharmaceutical Benefits Advisory Committee will consider the review. 

Further information including Terms of Reference to follow.